 Abnormal processing pro-IGF-II patients hepatoma hepatitis virus antibody-positive asymptomatic individuals Hepatomas common malignancy countries high prevalence hepatitis virus infections tumors severe persistent hypoglycemia possible relationship production insulin-like growth factor II IGF-II tumors development hypoglycemia Mean IGF-II concentration patients hypoglycemia patients euglycemia SE vs micrograms/L Serum IGF-I suppressed patients hypoglycemia micrograms/L patients euglycemia micrograms/L increased percentage IGF-II serum patients hypoglycemia tumors present pro-IGF-II big IGF-II sera patients hypoglycemia patients euglycemia hepatomas acidic Bio-Gel columns IGF-II sera patients hypoglycemia present big IGF-II patients euglycemia hepatomas different normal controls healthy control subjects hepatitis virus positive percentages big IGF-II abnormal processing pro-IGF-II subtle changes liver function infection subjects increased big IGF-II risk development hepatomas conclusion marked suppression IGF-I sera patients hepatoma hypoglycemia